Intraocular Bevacizumab Coding/Billing Guidelines - R8

The Intraocular Bevacizumab Coding/Billing Guidelines coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI) and 01312 (NV).

Effective Date: January 1, 2019
Summary of Changes: Updated to include HCPCS Q5107 injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg.

View the locally hosted Medicare coverage article.

View a complete list of Noridian coverage articles.

  • Go to Noridian Medicare Coverage Articles webpage
  • Scroll to bottom of page
  • Select state/contract link of interest from applicable Active, Future, or Retired Articles column
    • Link will redirect you to CMS MCD
  • In CMS MCD, select corresponding article title to view a comprehensive revision history for this article

 

Last Updated Jul 10, 2019